The company

The pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications.


Bart. van den Berg (MSc)
Joining the company in June 2004, Mr. van den Berg is former general manager and co-founder of two pharmaceutical contract manufacturing companies. Additionally, he founded VenGen BV, a life sciences start-up management company. He was trained in business economics at Tilburg University, the Netherlands.
Michiel Kregel, PhD
Operations Manager
Before joining Diagnoptics in 2013, Mr. Kregel worked as a product manager, a consultant in photonics and in spatial information technology. He has managed technical project teams in various settings, such as fluorescence microscopy and geodesy. He has a PhD in Astrophysics from The University of Groningen, The Netherlands.
Jasper Dijkstra (MSc)
Commercial Manager
Mr. Dijkstra has a Master’s degree Medical Biology from The University of Groningen, The Netherlands. During his master program he specialised in policy and business issues that are involved in life science innovation. Prior to joining Diagnoptics in 2009, Mr. Dijkstra worked as a Technology Transfer Officer at The University of Groningen.
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.


Our contact details

Diagnoptics Technologies B.V.
Aarhusweg 4-9
9723 JJ Groningen
The Netherlands

Tel: +31 (0)50 589 0612
Fax: +31 (0)50 589 0613

Follow us on LinkedIn

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.